| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 74.59B | 76.05B | 69.53B | 63.78B | 57.92B | 52.79B |
| Gross Profit | 13.36B | 13.68B | 12.44B | 11.37B | 10.28B | 9.00B |
| EBITDA | 10.40B | 9.87B | 12.98B | 8.81B | 7.91B | 6.36B |
| Net Income | 5.58B | 5.15B | 7.45B | 4.78B | 4.30B | 3.25B |
Balance Sheet | ||||||
| Total Assets | 86.54B | 88.95B | 79.97B | 66.65B | 58.94B | 50.34B |
| Cash, Cash Equivalents and Short-Term Investments | 17.24B | 17.36B | 17.34B | 11.74B | 14.72B | 12.77B |
| Total Debt | 29.17B | 30.08B | 26.03B | 22.17B | 19.58B | 15.94B |
| Total Liabilities | 44.44B | 47.32B | 42.08B | 35.60B | 32.13B | 27.14B |
| Stockholders Equity | 42.10B | 41.63B | 37.90B | 31.02B | 26.78B | 23.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.67B | -1.11B | -4.63B | -1.28B | -2.02B |
| Operating Cash Flow | 0.00 | 6.81B | 8.17B | 6.25B | 6.04B | 4.91B |
| Investing Cash Flow | 0.00 | -9.32B | -5.25B | -11.11B | -7.09B | -7.22B |
| Financing Cash Flow | 0.00 | 2.53B | 2.68B | 1.88B | 3.00B | 5.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥36.52B | 6.99 | ― | 3.01% | -1.93% | 47.35% | |
74 Outperform | ¥41.31B | 13.81 | ― | 3.86% | 14.97% | 72.48% | |
74 Outperform | ¥46.93B | 8.05 | ― | 6.02% | 1.33% | 9.59% | |
69 Neutral | ¥116.32B | 18.54 | 4.48% | 3.30% | -2.12% | 0.89% | |
68 Neutral | ¥53.62B | 10.25 | 6.98% | 7.35% | -21.50% | -56.82% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥74.70B | 14.08 | ― | 2.95% | 9.37% | -31.19% |